A prothrombotic state due to elevated fibrinogen level and fibrin degradation in the blood is also a pathophysiological feature of COVID-19, but patients show minor changes in prothrombin and activated partial thromboplastin time, activated protein C levels, and at the time of platelet count. The gene discussed is F2; the disease is COVID-19.